ScholarIQanswers from OpenAlex

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

PaperCitations, authors & open-access status

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives have?

ScholarIQcitation count

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives has 174 citations in the OpenAlex counts ScholarIQ stores.

When was A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives published?

ScholarIQyear

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives has 2015 year in the ScholarIQ index.

What is the open-access status of A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives?

ScholarIQoa status

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives has diamond oa status in the ScholarIQ index.

What is the DOI of A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives?

ScholarIQdoi

The DOI for A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives is on the source record.

What is the PMID of A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives?

ScholarIQpmid

The PMID for A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives is on the source record.

What is the OpenAlex record for A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives?

ScholarIQopenalex

The OpenAlex for A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial